The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies ...
Controls on drug prices will stifle our ability to innovate while also damaging the economy, Alexandria economist Justin Vélez-Hagan, Ph.D., writes in a guest column.
While so-called “march-in” rights have yet to materialize in the United States, the controversial measure to cut drug prices appears to be gaining traction with the government. | While so-called ...
The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...
State officials approached 23 drugmakers in the last year about an importation program. None expressed interest in ...
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
Under the Inflation Reduction Act (IRA) of 2022, the Centers for Medicare and Medicaid Services (CMS) will begin negotiating drug prices for a subset of drugs in Medicare. In doing so, CMS must ...
It was a huge defeat for Big Pharma when Congress and President Joe Biden enacted a law aimed in part at lowering ...
Joe Biden has made it less likely that we’ll find a cure for Alzheimer’s any time soon. That’s a consequence of his ordering Medicare to “negotiate” with pharmaceutical firms over the ...
A smarmy executive is all over Washington these days, which is really nothing new. But this particular suit is everywhere. And according to the lobbying group behind the commercials he stars in ...
